Long-Term Safety and Efficacy of 4-Weekly Certolizumab Pegol Combination and Monotherapy in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study

被引：0
|
作者：
Fleischmann, Roy M. [1 ]
van Vollenhoven, Ronald F. [2 ]
Vencovsky, Jiri [3 ]
Alten, Rieke [4 ]
Davies, Owen [5 ]
Stach, Christian [6 ]
de Longueville, Marc [5 ]
Van Lunen, Brenda [7 ]
Choy, Ernest [8 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Karolinska Inst, Stockholm, Sweden
[3] Inst Rheumatol, Prague, Czech Republic
[4] Univ Med Berlin, Schlosspk Klin, Berlin, Germany
[5] UCB Pharma, Brussels, Belgium
[6] UCB Pharma, Monheim, Germany
[7] UCB Pharma, Raleigh, NC USA
[8] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1316
引用
收藏
页码：S565 / S566
页数：2
相关论文
共 50 条
  • [1] LONG-TERM SAFETY OF 4-WEEKLY CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS: 5 YEAR RESULTS FROM AN OPEN LABEL EXTENSION STUDY
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Alten, R.
    Davies, O.
    Stach, C.
    de Longueville, M.
    van Lunen, B.
    Choy, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 523 - 523
  • [2] LONG-TERM SAFETY AND EFFICACY OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Alten, R.
    Davies, O.
    Stach, C.
    de Longueville, M.
    VanLunen, B.
    Choy, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 435 - 435
  • [3] LONG-TERM BENEFITS OF 4-WEEKLY CERTOLIZUMAB PEGOL COMBINATION AND MONOTHERAPY ON HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION IN RHEUMATOID ARTHRITIS: 5 YEAR RESULTS FROM AN OPEN LABEL EXTENSION STUDY
    Strand, V
    Purcaru, O.
    Van Vollenhoven, R.
    Choy, E.
    Fleischmann, R.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A451 - A452
  • [4] Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy On Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension Study
    Strand, Vibeke
    Purcaru, Oana
    van Vollenhoven, Ronald F.
    Choy, Ernest
    Fleischmann, Roy
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S567 - S567
  • [5] LONG-TERM BENEFITS OF 4-WEEKLY CERTOLIZUMAB PEGOL MONOTHERAPY AND COMBINATION THERAPY ON HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION IN RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM AN OPEN-LABEL EXTENSION STUDY
    Strand, V.
    Purcaru, O.
    van Vollenhoven, R.
    Choy, E.
    Fleischmann, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 441 - 442
  • [6] 5-YEAR RESULTS FROM THE RAPID 1 TRIAL AND OPEN-LABEL EXTENSION: LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Keystone, E.
    Landewe, R.
    van Vollenhoven, R.
    Combe, B.
    Strand, V.
    Mease, P. J.
    Shaughnessy, L.
    VanLunen, B.
    van der Heijde, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 228 - 229
  • [7] Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) : 2094 - 2100
  • [8] Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
    Fleischmann, Roy
    van Vollenhoven, Ronald F.
    Vencovsky, Jiri
    Alten, Rieke
    Davies, Owen
    Mountian, Irina
    de Longueville, Marc
    Carter, David
    Choy, Ernest
    [J]. RHEUMATOLOGY AND THERAPY, 2017, 4 (01) : 57 - 69
  • [9] Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
    Roy Fleischmann
    Ronald F. van Vollenhoven
    Jiri Vencovský
    Rieke Alten
    Owen Davies
    Irina Mountian
    Marc de Longueville
    David Carter
    Ernest Choy
    [J]. Rheumatology and Therapy, 2017, 4 : 57 - 69
  • [10] Long Term Tolerability and Efficacy of a 4-week-administration of Certolizumab pegol as Monotherapy and Combination Therapie in rheumatoid Arthritis-5-Year-Data of an open Extension Study
    Alten, R.
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Davies, O.
    Stach, C.
    de Longueville, M.
    VanLunen, B.
    Choy, E.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 111 - 111
12345